Purpose: To identify weak points in daily routine use of radiation therapy (RT) for non-metastatic breast cancer patients, particularly when data are lacking or equivocal, a “think tank” of experts met in Assisi. Methods: Before the meeting, controversial issues on non-metastatic breast cancer were identified and reviewed, and clinical practice investigated by means of an online questionnaire. During the 3-day meeting, topics were discussed in-depth with attendees and potential sponsors that are involved in breast cancer treatment. Results: Three issues were identified as needing further investigation: (1) Regional lymph node treatment in early-stage breast cancer; (2) Combined post-mastectomy RT and breast reconstruction; (3) RT in patients treated with primary systemic therapy. Future research proposals included the following: (1) Participating in appropriately selected on-going clinical trials; (2) Designing new randomized controlled clinical trials and prospective population cohort studies; (3) Setting-up large database(s) to generate predictive response models and detect biomarkers for tailored loco-regional treatments. Conclusions: It is hoped that the ATTM findings, as described in the present white paper, will stimulate a new generation of radiation oncologists to focus on research in these areas, and that the white paper will become a tool for multidisciplinary groups to help them design research proposals and strategies.

Aristei, C., Kaidar Person, O., Arenas, M., Coles, C., Offersen, B. V., Bourgier, C., Frezza, G., Leonardi, M. C., Valentini, V., Poortmans, P. M. P., The 2016 Assisi Think Tank Meeting on breast cancer: white paper, <<BREAST CANCER RESEARCH AND TREATMENT>>, 2016; 160 (2): 211-221. [doi:10.1007/s10549-016-3998-2] [http://hdl.handle.net/10807/92414]

The 2016 Assisi Think Tank Meeting on breast cancer: white paper

Aristei, Cynthia
;
Valentini, Vincenzo
Penultimo
;
2016

Abstract

Purpose: To identify weak points in daily routine use of radiation therapy (RT) for non-metastatic breast cancer patients, particularly when data are lacking or equivocal, a “think tank” of experts met in Assisi. Methods: Before the meeting, controversial issues on non-metastatic breast cancer were identified and reviewed, and clinical practice investigated by means of an online questionnaire. During the 3-day meeting, topics were discussed in-depth with attendees and potential sponsors that are involved in breast cancer treatment. Results: Three issues were identified as needing further investigation: (1) Regional lymph node treatment in early-stage breast cancer; (2) Combined post-mastectomy RT and breast reconstruction; (3) RT in patients treated with primary systemic therapy. Future research proposals included the following: (1) Participating in appropriately selected on-going clinical trials; (2) Designing new randomized controlled clinical trials and prospective population cohort studies; (3) Setting-up large database(s) to generate predictive response models and detect biomarkers for tailored loco-regional treatments. Conclusions: It is hoped that the ATTM findings, as described in the present white paper, will stimulate a new generation of radiation oncologists to focus on research in these areas, and that the white paper will become a tool for multidisciplinary groups to help them design research proposals and strategies.
2016
Inglese
Aristei, C., Kaidar Person, O., Arenas, M., Coles, C., Offersen, B. V., Bourgier, C., Frezza, G., Leonardi, M. C., Valentini, V., Poortmans, P. M. P., The 2016 Assisi Think Tank Meeting on breast cancer: white paper, <<BREAST CANCER RESEARCH AND TREATMENT>>, 2016; 160 (2): 211-221. [doi:10.1007/s10549-016-3998-2] [http://hdl.handle.net/10807/92414]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/92414
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact